Surgical Management of Dyslipidemia: Clinical and Experimental Evidence

References

• Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, McKillop JH, Packard CJ. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med. 1995;333:1301– 1307.
   Google Scholar
• Scandinavian Simvastatin Survival Study Group. Random- ized trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Sur- vival Study (4S). Lancet. 1994;344:1383 –1389.
   Google Scholar
• Pitt B, Mancini GB, Ellis SG, Rosman HS, Park JS, McGovern ME. Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC-I): Reduction in atherosclero- sis progression and clinical events. PLAC I investigation. J Am Coll Cardiol. 1995;26:1133 –11399.
   Google Scholar
• Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, Brown L, Warnica JW, Arnold JM, Wun CC, Davis BR, Braunwald E. The effect of pravas- tatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and recurrent events trial investigators. N Engl J Med. 1996;335:1001 –1009.
   Google Scholar
• Frohlich J, Fodor G, McPherson R, Genest J, Langner N. Rationale for and outline of the recommendations of the working group on thypercholesterolemia and other dyslipidemias: Interim report. Dyslipidemia working group of Health Canada. Can J Cardiol. 1998;14 (suppl A):17A–21A.
   Google Scholar
• National Cholesterol Education Program. Second report of the expert panel on detection, evaluation, and treatment of blood cholesterol in adults (Adult treatment panel II). Circulation. 1994;89:1329 –1445.
   Google Scholar
• Mustad VA, Kris-Etherton PM. Beyond cholesterol low- ering: Deciphering the benefts of dietary interven- tion on cardiovascular diseases. Curr Atheroscler Opin. 2000;2:461–466.
   PubMedGoogle Scholar
• Moghadasian MH, Frohlich JJ. Effects of dietary phy- tosterols on cholesterol metabolism and atherosclero- sis: Clinical and experimental evidence. Am J Med. 1999;107:588 –594.
   Google Scholar
• Salen G, Shefer S, Nguyen L, Ness GC, Tint GS, Shore V. Sitosterolemia. J Lipid Res. 1992;33:945 –955.
   Google Scholar
• Buchwald H. Lowering of cholesterol absorption and blood levels by ileal exclusion: Experimental basis and preliminary clinical report. Circulation. 1964;29:713 – 720.
   Google Scholar
• Buchwald H, Varco RL, Moore RB, Schwartz MZ. Intestinal bypass procedures: Partial ileal bypass for hyperlipidemia and jejunoileal bypass for obesity. Curr Problems Surg. 1975;12:1–51.
   Google Scholar
• Yamamoto T, Yamamoto M, Ohyanagi H, Saitoh Y, Akiyoshi T, Uchida K. The prevention of experimental cholesterol gallstones by ileectomy in mice. Jpn J Surg. 1998;18:316–325.
   Google Scholar
• Buchwald H, Moore RB, Lee GB, Frantz ID, Varco RL. Treatment of hypercholesterolemia. Combined dietary, surgical and bile salt binding resin therapy. Arch Surg. 1968;97:275–281.
   PubMedGoogle Scholar
• Campos CT, Matts JP, Fitch LL, Speech JC, Long JM, Buchwald H, POSCH group. Lipoprotein modifcation achieved by partial ileal bypass: Five year results of the Pro- gram on the Surgical Control of Hyperlipidemias. Surgery. 1987;102:424 –431.
   Google Scholar
• Buchwald H, Moore RB, Varco RL. Ten years clinical ex- perience with partial ileal bypas in managemen t of the hyperlipidemias. Ann Surg. 1974;180:384 –392.
   Google Scholar
• Koivisto P, Miettinen TA. Long-term effect of ileal by- pass on lipoproteins in patients with familial hypercholes- terolemia. Circulation. 1984;70:290 –296.
   Google Scholar
• Ohri SK, Leane PF, Swift l, Sackier JM, Williamson RCN, Thompson GR, Wood CB. Reapprasial of partial ileal by- pass for the treatment of familial hypercholesterolemia. Am J Gastroenterol. 1989;84:740 –743.
   Google Scholar
• Issa JS, Garrido A jr, Giannini SD, Forti N, Diament J, Pinotti HW. Clinical outcome of patients with familial hy- percholesterolemia and coronary artery disease undergo- ing partial ileal bypass. Arq Bras Cardiol. 2000;75:49–58.
   PubMedGoogle Scholar
• Lopez-Santamaria M, Migliazza L, Gamez M, Murica J, Diaz-Gonzalez M, Camarena C, Hierro L, De la Vega A, Frauca E, Diaz M, Jara P, Tovar J. Liver transplanta- tion in patients with homozygotic familial hypercholes- terolemia previously treated by end-to-side portocaval shunt and ileal bypass. J Pediatr Surg. 2000;35:630– 633.
   Google Scholar
• Balfour JF, Kim R. Homozygous type ll hyperlipidemia treatment: Partial ileal bypass in two children. J Am Med Assoc. 1974;227:1145 –1151.
   Google Scholar
• Russell D, Fritz V, Mieny CJ, Mendelson D, Joffe Bl, Seftel HC. Treatment of familial hypercholesterolemia by partial ileal bypass. S Afr Med. 1979;55:237 –240.
   Google Scholar
• Swan DM, McGowan JM. Ileal bypass in hypercholes- terolemia associated with coronary heart disease. Am J Surg. 1968;116:22 –27.
   Google Scholar
• Buchwald H, Moore RB, Ducker RD Jr, Amplatz K, Castaneda WR, Francoz RA, Pasternak RC, Varco RL. Clinical angiographi c regression of atherosclerosis af- ter partial ileal bypass. Atherosclerosis. 1983;46:117– 128.
   Google Scholar
• Schouten JA, Beynen AC, Hoitsma HF, Meijer S, Res J, Van Gent CM. Partial ileal bypass surgery in the treatment of familial hypercholesterolaemia. Report of two cases. Neth J Med. 1985;28:356 –360.
   Google Scholar
• MJTM, Stalenhoef AFH, Demacker NM, van’t Laar A. Low-density lipoprotein catabolism in WHHL rabbits after partial ileal bypass surgery. Biochim Biophys Acta. 1989;1003:167 –174.
   Google Scholar
• Stalenhoef AFH, van Niekerk JLM, Demacker PNM, van’t Laar A. Partial ileal bypass reduces the production rate of low density lipoproteins in Watanabe heritable hyperlipidemic rabbits. J Lipid Res. 1984;25:1350 –1357.
   Google Scholar
• van Niekerk JLM, Demacker PNM, Hendriks TH, De Boer HHM. Partial ileal bypass inhibits atherosclerosis in WHHL rabbits. Atherosclerosis. 1983;48:243–252.
   PubMed Web of Science ®Google Scholar
• van Niekerk JLM, Demacker PNM, Hendriks TH, De Boer HHM. A comparative study on serum lipids and atherosclerotic plaque formation in diet-induced and familial hypercholesterolemia in rabbits, and the effect of partial ileal bypass. Artery. 1985;12:263–276.
   PubMedGoogle Scholar
• Buchwald H, Frantz ID Jr, Gebhard RL, Moore RB. Ileal bypass versus ileal excision: Effects on cholesterol synthesis and whole blood cholesterol concentrations in the rabbit. Surg Clin North Am. 1967;49:1353 –1362.
   Google Scholar
• Tijerina O, Dombrovskis S, Esper E, Matts JP, Campos CT, Buchwald H. Low plasma lipid levels and increased cholesterol synthesis after partial ileal bypass plus lovastatin in hypercholesterolemic rabbits. Surgery. 1988;104:796 –805.
   Google Scholar
• Schouten JA, Beynen AC, Hoitsma HFW, Mulder C, Havekes LM, Vagent CM. Serum lipoproteins in cholesterol-fed pigs after partial ileal bypass. Lab Anim. 1985;19:98–105.
   PubMed Web of Science ®Google Scholar
• Schouten JA, Beynen AC, Popp-Snijiders C, Mulder C, van Blitterswijik WJ, Hoitsma HFW. The composition of plasma lipoproteins and erythrocyte membranes in cholesterol-fed pigs with partial ileal bypass. Artery. 1987;14:165 –189.
   Google Scholar
• Schouten JA, Beynen AC, De Rooy PD, Hoitsma HFW, Bosma A. Long-term effects of partial ileal bypass on the health status of rabbits. Lab Anim. 1986;20:148– 153.
   Google Scholar
• Faergeman O, Meinertz H, Hylander E, Fischerman K, Jarnum S, Nielsen OV. Effects and side-effects of partial ileal bypass surgery for familial hypercholesterolemia. Gut. 1982;23:558 –563.
   Google Scholar
• Buchwald H, Moore RB, Varco R. Clinical status of partial ileal bypass operation. Circulation. 1974;49 (suppl):122–137.
   Google Scholar
• Illingworth DR, Connor WE. Hypercholesterolemia per- sisting after distal ileal bypass: Response to mevinolin. N Engl J Med. 1984;100:850 –851.
   Google Scholar
• Moghadasian MH. Clinical pharmacology of 3-hydroxy- 3-methylglutaryl coenzyme A reductase inhibitors. Life Sci. 1999;65:1329–1337.
   PubMed Web of Science ®Google Scholar